Hot Flasher Weekly Recap — June 15 - June 19, 2026

Here’s everything we covered this week on Hot Flasher.

MONDAY — Botanicals, Trauma, and High Altitude: Three Surprising Menopause Studies

6:14 min

Three new studies reveal surprising aspects of menopause: a promising botanical treatment for hot flashes with solid clinical trial backing, research connecting childhood trauma to worse menopausal symptoms, and fascinating findings on how estrogen loss affects women’s bodies even in extreme environments like high-altitude Nepal.

Key Takeaways:

• A new botanical compound targeting neurokinin pathways showed significant reduction in hot flash frequency in a randomized controlled trial

• Women with adverse childhood experiences report more severe menopausal symptoms and worse quality of life during the transition

• Post-menopausal Tibetan women at high altitude show altered cardiovascular responses to low oxygen, suggesting estrogen’s protective effects extend to extreme environments

Sources:

• Adverse childhood experiences linked to worse menopause symptoms and quality of life

Listen to this episode →

TUESDAY — When ‘You Can’t Take HRT’ Means ‘Your Doctor Hasn’t Read the Evidence’

13:14 min

The New York Times framed this weekend’s piece as women being ‘left out’ of hormone therapy. We take a closer look at one of the three women profiled and argue that at least one of these stories isn’t a contraindication — it’s a provider-knowledge gap. The Menopause Society’s own 2022 position on transdermal estrogen and clot risk has been clear for years; the question is whether your doctor has read it.

Key Takeaways:

• The Menopause Society’s 2022 Hormone Therapy Position Statement says transdermal routes and lower doses may decrease the risk of VTE compared to oral estrogen

• Dr. Stephanie Faubion, quoted in the same NYT piece, is the medical director of The Menopause Society — and has been publishing on the route-of-administration distinction for years

• Dr. Rajita Patil at UCLA called the provider-knowledge gap ‘humongous’; many clinicians are still not up to speed on transdermal estrogen, micronized progesterone, or testosterone

Sources:

• Millions of Women Can’t Take Hormone Therapy. Here’s What They Want You to Know (NYT, 2026-06-15)

• The Menopause Society — 2022 Hormone Therapy Position Statement

• Find a Menopause Society Certified Practitioner

Listen to this episode →

WEDNESDAY — Your Brain Called. It Wants You to Take Perimenopause Sleep Seriously.

9:21 min

This episode covers three studies from the NAMS journal, all landing in the same week with myth-busting implications. Perimenopausal sleep disruption may have lasting effects on cognitive function; statins carry memory-related effects worth knowing about even as they protect the heart; and a novel non-hormonal device for genitourinary syndrome of menopause is showing early promise for women who thought vaginal symptoms were just something to live with.

Key Takeaways:

• Women frequently woken by menopausal symptoms during perimenopause showed measurably poorer cognitive function decades later, suggesting sleep disruption in midlife is a marker worth taking seriously — not just waiting out.

• Statin therapy in postmenopausal women was not linked to mild cognitive impairment overall, but was associated with poorer delayed recall memory and visuospatial function, as well as higher menopausal symptom burden and sarcopenia risk.

• The cognitive and somatic effects of statins can overlap with menopausal symptoms, which matters when doctors are trying to sort out what’s causing what in a postmenopausal patient.

Sources:

• Perimenopausal sleep disturbances linked to poorer cognitive function decades later

• Statin use in postmenopausal women associated with poorer memory and higher menopausal symptom burden

• Negative pressure device shows feasibility for treating genitourinary syndrome of menopause

Listen to this episode →

THURSDAY — Your Genes, Your Body Image, and a Vacuum for Your Vagina

10:19 min

This episode covers a 2026 study on how the APOE4 gene variant disrupts the brain’s energy metabolism during menopause, Shania Twain’s candid comments about body image after menopause, and a small pilot study on a negative pressure device for genitourinary syndrome of menopause. Three genuinely different topics, all worth knowing about this week.

Key Takeaways:

• Women who carry the APOE4 gene variant may experience a more pronounced disruption in how brain cells switch fuel sources during the menopause transition — a shift that some researchers connect to elevated Alzheimer’s risk in this population.

• The brain’s preferred fuel source shifts from glucose to ketone-based metabolism during menopause; APOE4 appears to interfere with that adaptive process, according to a 2026 study by Wang et al.

• Shania Twain publicly described menopause as having improved her relationship with her body — a notable counternarrative to the predominantly negative media framing of this life stage.

Sources:

• APOE4 accelerates menopause-associated brain metabolic shift and disrupts bioenergetic adaptation

• Shania Twain says menopause improved her body image

• Novel negative pressure treatment for genitourinary syndrome of menopause: feasibility pilot study with the VITA AV system

Listen to this episode →

FRIDAY — Your Body Is a Portal (And Low-Fat Diets Don’t Protect Your Brain)

10:15 min

Dr. Hillary McBride’s work on embodiment reframes menopause as a psychological and cultural turning point, not just a hormonal one. A new cross-sectional study links cardiorespiratory fitness to fewer menopause symptoms and a better cardiometabolic profile. And a secondary analysis of the Women’s Health Initiative finds that a low-fat dietary pattern did not reduce dementia mortality in postmenopausal women.

Key Takeaways:

• Dr. Hillary McBride’s research suggests the cultural stories women absorb about aging can shape the physical and psychological experience of menopause itself.

• A cross-sectional study published in the NAMS journal found cardiorespiratory fitness was independently associated with a more favorable cardiometabolic risk profile and fewer menopause-related symptoms in midlife women.

• The same study did not find a significant association between cardiorespiratory fitness and vascular function, suggesting other factors drive vascular health during the transition.

Sources:

• Menopause Is a Portal: Reclaiming the Body, the Story, and the Second Half with Dr. Hillary McBride

• Cardiorespiratory fitness, cardiovascular disease risk factors, and quality of life in perimenopausal and postmenopausal women

• Low-fat dietary pattern and dementia mortality: secondary analysis of the Women’s Health Initiative

Listen to this episode →

Thanks for listening this week.

Got a menopause story to share? Tell us about it →

— Hot Flasher
hotflasher.com